Cite

HARVARD Citation

    Galanina, N. et al. (2017). Ofatumumab monotherapy in relapsed/refractory diffuse large B-cell non-Hodgkin lymphoma. Leukemia & lymphoma. 58 (3), pp. 752-753. [Online]. 
  
Back to record